Minocycline Augmentation of Clozapine for Treatment Resistant Schizophrenia

NCT02533232 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder
Schizophreniform Disorder

Interventions

DRUG: Minocycline

Sponsor

Pakistan Institute of Living and Learning